Pediatrician explains enterovirus D68 illness
The Centers for Disease Control is warning of a spike in cases of a rare respiratory illness identified as enterovirus D68 that is sickening children in about a dozen states, though none have...
By: UMass Medical School
Read more:
VACCINE BEAT #2 - What Doctors Learn About Vaccines
When you take your child to the doctor for routine vaccines you can rest assured that your doctor knows all he or she needs to know about vaccines, right? You can safely assume that he or she...
By: GreaterGoodMovie
Read the rest here:
SPOKANE Washington State University is well-positioned to develop an accredited medical school by 2017 with a relatively modest investment from the state, says a study commissioned by the university and released Thursday.
University of Washington officials said they were disappointed WSU is continuing to pursue its own medical school and urged the other university to put aside its individual institutional ambitions to focus on whats best for the state.
Washington State University already has the physical capacity and experience to open a new medical school it has a health-sciences campus in Spokane and has participated in the WWAMI medical-education program run by the University of Washington for 43 years, the WSU study noted. The program trains students to become doctors in Washington, Wyoming, Alaska, Montana and Idaho.
The study underscored the significant and growing statewide need for more doctors, especially outside the Seattle region. And it found that a medical school in Spokane could double the number of in-state medical-school graduates during the next decade, with no capital expenditure.
Consultants said it would cost $1million to $3 million per year in state funds during the next few years to start the school. Funding needs would increase gradually, up to $47 million annually when the school reaches an enrollment of 480 students in 2024-25. Of that, $29 million annually would come from the state.
Even before WSUs regents had finished their meeting, UW officials released the statement questioning the need for another medical school.
We believe creating a second, $47 million medical school raises many questions and concerns about the highest and best use of limited resources, said UW Regent Orin Smith in a prepared statement.
Addressing our health-care disparities in Eastern Washington and growing an innovative, sustainable economy in Spokane demand that we put aside individual institutional ambitions and focus on what is best for our students, the Spokane community and the state, he said.
The states two largest universities have been waging a turf war for more than a year over WSUs aspirations for a medical school. UW officials fear another school could draw faculty, students and state funding away from the WWAMI program and say a more cost-effective way to expand medical training is to grow WWAMI.
A task force convened by UW President Michael Young, and chaired by former Gov. Dan Evans, will release a report in October on the future of WWAMI and how best to boost medical-school education.
More here:
Study says med school feasible in Spokane
By Nicholas K. Geranios Associated Press
SPOKANE Washington State University is well-positioned to develop an accredited medical school in the near future with a relatively modest investment from the state.
Thats the conclusion of a feasibility study released Thursday and commissioned by Washington State University.
The study found there is a significant and growing statewide need for more doctors, especially outside the Seattle metropolitan areas.
The study found that Washington State University already has significant assets and long experience training medical students because of its health sciences campus in Spokane and its participation in the WWAMI medical education program operated by the University of Washington.
The study found a medical school in Spokane could double the number of in-state students graduating from medical schools over the next decade, with no capital expenditure.
Sign up for HeraldBizNet newsletter
Originally posted here:
Dr. James Dunphy met his wife Susie in college. They went to medical school together, got married and had two sons. On a family trip to Florida in 2009, Dr. Susie Dunphy was diagnosed with appendicitis. She had emergency surgery; two days later the 42-year-old bled to death in her hospital bed.
Drs. James and Susie Dunphy with their children
James Dunphy said the hardest part was breaking the news to his two young boys.
"I told them it would be okay, and that I would be their mom and dad now," Dunphy said.
In the weeks after her death, Dunphy reviewed his wife's medical file. What he read convinced him that her doctor could have prevented her death. He said his wife's blood pressure had been critically low for hours after the surgery. But no lab tests or imaging studies were ordered to see what was wrong.
"These are the kind of vitals that anybody with basic training can recognize as abnormal," Dunphy told CBS News.
Dunphy sued his wife's surgeon for failing to adequately monitor her after the procedure, blaming him in part for her death.
Dr. Ernest Rehnke has had 11 medical malpractice lawsuit payouts since 2000 - tying him for the most of any practicing physician in Florida.
See the rest here:
Despite multiple malpractice payouts, doctors often keep practicing
Published: Thursday, September 11, 2014 at 5:34 p.m. Last Modified: Thursday, September 11, 2014 at 5:34 p.m.
But Dec. 22 was the day that threatened to rob Lowther of everything. It was the day she was diagnosed with leukemia, a day she remembers vividly almost a year later.
Lowther, 29, has since reclaimed the ambition that chemotherapy strangled from her, with plans to return to medical school in January.
The Florida woman also spent most of August training for a 26-mile inline skating marathon Saturday in Minnesota to raise funds for her doctor's cancer research, all while receiving regular chemotherapy. Her resolve is a far cry from the woman she was that December night, angered and in disbelief.
She had been suffering from chronic headaches and visited an urgent care clinic to see a doctor, get a prescription and get back to her studies at the Lake Erie College of Osteopathic Medicine in Bradenton.
But the doctor returned with startling news: Lowther's white blood cell count was 64,000 cells per microliter, far outside the normal range. The medical student knew exactly what that could mean cancer.
At that point, doctors determined she should travel to UF Health Shands Hospital in Gainesville to receive treatment immediately. She was heavily anemic and too weak to travel, so she was given a blood transfusion at the local hospital, still wearing her pajamas from the previous day.
During the three-hour ambulance ride to Gainesville, she began connecting the dots.
Her past year was pockmarked with unexplained illnesses, fainting spells and an elevated heart rate. She had chalked it up to stress and energy drinks third-year medical students aren't always the healthiest individuals but now those incidents were symptoms of something more serious. Something deadly.
The diagnosis was unusual: acute lymphoblastic leukemia, a disease typically found in children or the elderly. Her bone marrow was producing unformed white blood cells at an alarming rate, smothering everything else in her blood.
See more here:
Resilient college student shines while being treated for cancer at Shands
The Washington Alliance of Teaching Physicians is stepping up its efforts to support a fully accredited medical school in Spokane, say Spokane physicians Jeremy Graham and Henry Mroch, spokesmen for the ad hoc group.
Representatives of ATP, which is made up of a few dozen, mostly Spokane-area physicians, have been meeting with legislators sporadically and now want to bring their message to Gov. Jay Inslee.
Were clinical doctors, not activists, says Graham. Weve been meeting with legislators. We have an effort under way now to urge the governor to meet with us. We perceive the governor, like a lot of legislators, doesnt have information about whats available or not available in Spokane without a real medical school here.
ATP also supports efforts of Greater Spokane Incorporated to create awareness that the need for a second medical school in Washington state rises above the debate over whether Pullman-based Washington State University, or Seattle-based University of Washington would run it.
Most importantly, Graham and Mroch say, a second medical school is needed here to address a physician shortage in most counties throughout the state.
The physician shortage is real. Its something thats happening, not something that might happen, Mroch says, adding that nearly half of the counties in the state have only one doctor per 1,000 population, while the national average is around 2.7 doctors per 1,000.
Central and Eastern Washington are especially underserved, he says.
The existing medical programs here include UWs five-state WWAMI program, which needs to grow to benefit the entire state, Graham says.
The best partner to make that happen is a new fully accredited medical school, he says.
WWAMIwhich stands for Washington, Wyoming, Alaska, Montana, and Idahodoesnt contribute what a full medical school brings to the economy, he contends.
Read the original post:
Washington Alliance of Teaching Physicians plugs creation of medical school in Spokane
What Is The Definition Of Axelrod, Julius Medical Dictionary Free Online
what is the definition of Axelrod, Julius: (1912-2004 ) American pharmacologist and neuroscientist who shared the 1970 Nobel Prize in Physiology or Medicine for his discovery of the actions...
By: Medical Dictionary Online
View original post here:
What Is The Definition Of Axelrod, Julius Medical Dictionary Free Online - Video
Health First Family Medicine- 801-542-8080- West Jordan Family Doctor
6933 South !300 West West Jordan Utah visit-http://www.westjordanfamilydoctor.com/ Dr. Darren Jenkins has returned to Utah after 7 years of medical training. He attended Medical School at...
By: 24 Utah Video
Read more:
Health First Family Medicine- 801-542-8080- West Jordan Family Doctor - Video
If the United States is serious about diversifying its health care workforce, then medical schools can't afford to overlook campuses where many students from underrepresented minorities and low-income families get their start in higher education.
Welcome to America's community colleges.
That was the overall conclusion from authors of a study titled "Community College Pathways: Improving the U.S. Physician Workforce Pipeline." The study recently was published online(journals.lww.com) ahead of print by the journal Academic Medicine.
Lead author Efrain Talamantes, M.D., M.B.A., told AAFP News that he and his co-authors set out to discover the role community colleges play as a pathway to medical school admission. The primary outcome measure was acceptance to a U.S. allopathic medical school or medical scientist training program (MSTP). Additional outcome measures were students' plans to practice in an underserved community or to work primarily with minority populations.
Understanding that learners use community colleges in a variety of ways, researchers defined four community college pathways:
In this setting, students who attended community college after high-school graduation were considered "traditional" students.
Talamantes, an internal medicine physician, is a National Research Service Award Scholar in the Division of Internal Medicine and Health Service's Research at the University of California, Los Angeles. He said the community college research was done with the blessing of the Association of American Medical Colleges (AAMC), which administers the Medical College Admission Test.
"This study shows that students are getting into medical school from the community college pathway and that is hugely important. Many of those who are getting in are minority students and the first in their families to go to college," Talamantes added.
However, researchers also found that students in one particular pathway -- those who graduated from high school and then attended community college before they transferred to a four-year university -- were less likely to be accepted into medical school when compared with those in the other pathways.
Specifically, authors noted that 17,518 students (out of 40,491 applicants) matriculated into medical school in 2012; of that total, 4,920 used one of the community college pathways. So overall, 11 percent of those who matriculated attended community college during high school, and 12 percent attended community college after graduating from a four-year university.
See the article here:
Are U.S. Medical Schools Overlooking Community College Grads?
Contact Information
Available for logged-in reporters only
Newswise SEPTEMBER 10, 2014 (Lisbon, Portugal) Six Harvard Medical School (HMS) researchers were among the recipients of the 2014 Antnio Champalimaud Vision Award, the highest distinction in ophthalmology and visual science.
The award was given for the development of anti-angiogenic therapy for retinal disease. The researchers include Joan Whitten Miller, M.D., Evangelos S. Gragoudas, M.D., and Patricia A. DAmore, Ph.D., MBA, of Massachusetts Eye and Ear; Lloyd Paul Aiello, M.D., Ph.D., of Mass. Eye and Ear and Joslin Diabetes Center; George L. King, M.D., of Joslin Diabetes Center; and Anthony P. Adamis, M.D., of Genentech, who is also affiliated with HMS Ophthalmology and Mass. Eye and Ear. Napoleone Ferrara, M.D., of University of California, San Diego School of Medicine and Moores Cancer Center, also received the award.
The 2014 Antnio Champalimaud Vision Laureates were honored on Sept. 10, 2014 during a ceremony held at the Champalimaud Centre for the Unknown in Lisbon, Portugal. Presiding at the ceremony was His Excellency Anbal Antnio Cavaco Silva, President of the Portuguese Republic.
Established by The Champalimaud Foundation in 2006, the Antnio Champalimaud Vision Award honors outstanding contributions to the preservation and understanding of sight. In even-numbered years, the award is given for vision research, and in alternate years it recognizes efforts to alleviate visual problems in developing countries or through humanitarian endeavors.
Award recipients are selected by an international jury panel that includes two Nobel Laureates and other prominent figures. The Champalimaud Vision Award is often referred to as the Nobel Prize for Vision and with its 1 million ($1.3 million USD) purse, it is among the worlds largest scientific and humanitarian prizes.
In the 1990s, the 2014 Champalimaud Award Laureates worked in parallel and in collaboration to identify vascular endothelial growth factor (VEGF) as the major trigger for angiogenesis in the eye. Angiogenesis, or blood vessel growth, underlies the pathology of various blinding retinal disorders, including age-related macular degeneration (AMD) and diabetic retinopathy. Abnormal vascular growth a process called neovascularizationabove or below the retina allows fluid to leak into the central retina, causing vision loss.
The researchers then demonstrated that blocking VEGF could suppress ocular angiogenesis. This biomedical breakthrough led to a new class of ophthalmic anti-VEGF drugs, which first became available in the United States December 2004 with the introduction of pegaptanib (Macugen) for the neovascular or wet form of AMD. Multiple ophthalmic drugs targeting VEGF activity have since followed, including the widely used ranibizumab (Lucentis), introduced June 2006, and aflibercept (Eylea), introduced November 2011. Bevacizumab (Avastin), an anti-VEGF drug originally developed for cancer and introduced February 2004, is also widely used for treating retinal disease.
The development of anti-VEGF therapy for retinal disease is considered one of the top biomedical advances of the past decade. In 2006, the development of ranibizumab for neovascular AMD was featured in Breakthrough of the Year, a list of the 10 most significant scientific developments compiled annually by the journal Science.
Read more from the original source:
Harvard Medical School Researchers Awarded Prestigious $1.3M Champalimaud Vision Award
PUBLIC RELEASE DATE:
10-Sep-2014
Contact: Mary Leach Mary_Leach@meei.harvard.edu Massachusetts Eye and Ear Infirmary @MassEyeAndEar
SEPTEMBER 10, 2014 (Lisbon, Portugal) Six Harvard Medical School (HMS) researchers were among the recipients of the 2014 Antnio Champalimaud Vision Award, the highest distinction in ophthalmology and visual science.
The award was given for the development of anti-angiogenic therapy for retinal disease. The researchers include Joan Whitten Miller, M.D., Evangelos S. Gragoudas, M.D., and Patricia A. D'Amore, Ph.D., MBA, of Massachusetts Eye and Ear; Lloyd Paul Aiello, M.D., Ph.D., of Mass. Eye and Ear and Joslin Diabetes Center; George L. King, M.D., of Joslin Diabetes Center; and Anthony P. Adamis, M.D., of Genentech, who is also affiliated with HMS Ophthalmology and Mass. Eye and Ear. Napoleone Ferrara, M.D., of University of California, San Diego School of Medicine and Moores Cancer Center, also received the award.
The 2014 Antnio Champalimaud Vision Laureates were honored on Sept. 10, 2014 during a ceremony held at the Champalimaud Centre for the Unknown in Lisbon, Portugal. Presiding at the ceremony was His Excellency Anbal Antnio Cavaco Silva, President of the Portuguese Republic.
Established by The Champalimaud Foundation in 2006, the Antnio Champalimaud Vision Award honors outstanding contributions to the preservation and understanding of sight. In even-numbered years, the award is given for vision research, and in alternate years it recognizes efforts to alleviate visual problems in developing countries or through humanitarian endeavors.
Award recipients are selected by an international jury panel that includes two Nobel Laureates and other prominent figures. The Champalimaud Vision Award is often referred to as the "Nobel Prize for Vision" and with its 1 million ($1.3 million USD) purse, it is among the world's largest scientific and humanitarian prizes.
In the 1990s, the 2014 Champalimaud Award Laureates worked in parallel and in collaboration to identify vascular endothelial growth factor (VEGF) as the major trigger for angiogenesis in the eye. Angiogenesis, or blood vessel growth, underlies the pathology of various blinding retinal disorders, including age-related macular degeneration (AMD) and diabetic retinopathy. Abnormal vascular growth a process called neovascularizationabove or below the retina allows fluid to leak into the central retina, causing vision loss.
The researchers then demonstrated that blocking VEGF could suppress ocular angiogenesis. This biomedical breakthrough led to a new class of ophthalmic anti-VEGF drugs, which first became available in the United States December 2004 with the introduction of pegaptanib (Macugen) for the neovascular or "wet" form of AMD. Multiple ophthalmic drugs targeting VEGF activity have since followed, including the widely used ranibizumab (Lucentis), introduced June 2006, and aflibercept (Eylea), introduced November 2011. Bevacizumab (Avastin), an anti-VEGF drug originally developed for cancer and introduced February 2004, is also widely used for treating retinal disease.
Original post:
HMS/Mass. Eye and Ear researchers awarded prestigious Champalimaud Vision Award
He seemed like the Doogie Howser of India, able to crack the countrys best medical school, and work there as a 21-year-old doctor. Anoop Shankar later claimed to add a Ph.D. in epidemiology and treat patients even as he researched population-wide diseases. He won a genius visa to America, shared millions in grants, and boasted of membership in the prestigious Royal College of Physicians.
In 2012 West Virginia University hand-picked this international star to help heal one of the countrys sickest states. At just 37, Shankar was nominated to the first endowed position in a new School of Public Health, backed by a million dollars in public funds. As chair of the epidemiology department, he was also poised to help the university spend tens of millions of additional tax dollars. This is about improving healthcare and improving lives, said university president Jim Clements, announcing a federal grant for health sciences. We could not be more proud.
But there was a problem: Shankar isnt a Ph.D. He didnt graduate from the Harvard of India. He didnt write dozens of the scholarly publications on his resume, and as for the Royal College of Physicians, theyve never heard of him. He does have a masters degree in epidemiology from the University of North Carolina and an Indian medical degree, but at least two of his green card referencesattesting to world class creativity, genius insight, and a new avenue for treating hypertensionwere a forgery.
These are just some of the results of an inquiry into Shankars history, one that began as a standard pre-appointment review only to dilate into an ongoing, overlapping 18-month investigation. The case has captured the attention of two WVU offices, the Monongalia County courts, U.S. Immigration, and, in a lead role, Ian Rockett, chair of the promotion and tenure committee at the School of Public Health.
NBC News spoke with people familiar with all three probes and reviewed Rocketts 91-page report on Shankar, prepared partly in support of a lawsuit against his former colleague. Those documents, and several of Shankars colleagues, tell a similar story, describing a charming, bright-minded impostor who built a career on a base of lies.
His case exposes some of the profound dysfunction sometimes attributed to higher education, where the sanctity of research is threatened by skyrocketing retractions, epic frauds, and a system that seems ill-equipped to police itself. When you leave institutions in charge of an investigation, rather than, say, an outside watchdog organization, you are leaving the fox in charge of the henhouse, says Ivan Oransky, a founder of the whistleblower blog Retraction Watch.
"How many more are out there?"
Although Shankar was forced out of WVU in December of 2012, the university has yet to address the case publicly, allowing Shankar and his work to continue unchallenged. In the last year alone, hes published at least three papers, including one in the prestigious Journal of the American Medical Association. He also landed a new job on the backs of taxpayers: associate professor of family medicine at Virginia Commonwealth University, a large public university in Richmond.
In response to questions from NBC News, WVU pledged to make a complete and full public statement when all the facts are clear and known. But in the meantime, Shankarwho repeatedly postponed interviews after NBC made multiple attempts to reach him over the course of several monthshas both an untarnished record and his green card, and he continues self-inventing.
I have never wittingly seen his kind before, says Rockett, who went public to raise awareness of academic fraud. How many more are out there?
Read the rest here:
Medical School - Parkinson #39;s Disease
Support parkinson #39;s disease efforts: https://www.michaeljfox.org Get Involved! Website: http://www.imedicalschool.org Follow us on twitter: https://twitter.com/iMedSchool Follow us on Facebook:...
By: iMedicalSchool
Read this article:
Clay Johnston on UT #39;s Dell Medical School
We interviewed Dr. Clay Johnston, Dean of UT Austin #39;s new Dell Medical School, on his goals for the new medical school and how it will serve students.
By: The Daily Texan
Link:
5 years on
Song written by Peter Breakey for Brighton and Sussex Medical School. Class of 2014.
By: Peter Breakey
Visit link:
Coach Calhoun Dunks UConn Medical School Dean in Ice Bucket Challenge
Former UConn men #39;s basketball coach Jim Calhoun knows how to dunk and he used his talent to douse Dr. Frank Torti, medical school dean and EVP for health affairs, with a bucketful of...
By: uconnhealth
Read more from the original source:
Coach Calhoun Dunks UConn Medical School Dean in Ice Bucket Challenge - Video
Prescribing farm fresh food
Three UMass Medical School students launched a prescription program for free, fresh produce for patients at Family Health Center of Worcester, according to an article in the Telegram...
By: UMass Medical School
View post:
Medical School Admissions: How To Write a Good Personal Statement
The Pulse is Kaplan #39;s monthly series for pre-meds. In this video, our experts give tips on how to write a good personal statement for your medical school application. On the June episode,...
By: KaplanMCAT
See the original post here:
Medical School Admissions: How To Write a Good Personal Statement - Video
Contact Information
Available for logged-in reporters only
Newswise HOUSTON (Sept. 8, 2014) Hispanic Business magazine has ranked The University of Texas Health Science Center at Houston (UTHealth) Medical School among the top five medical schools in the country for promoting and encouraging a diverse community where Hispanic students can thrive.
The UTHealth Medical School was ranked No. 4 in the magazines 2014 Top 10 Medical Schools for Hispanic Students.
We are proud that the UTHealth Medical School has been recognized again for its dedication to recruit and educate Hispanic students, said UTHealth President Giuseppe Colasurdo, M.D. We will continue to reach out to students who are underrepresented in medicine. They will become physicians uniquely placed to treat a diverse patient population.
Institutions were ranked according to enrollment, number of Hispanic faculty and programs to attract and retain Hispanic students. The schools on our lists are well-rounded and have made notable efforts to engage the Hispanic community, the magazine said in its story on the rankings.
Hispanic students make up 13 percent of the enrollment at the UTHealth Medical School and Hispanic faculty account for 7 percent of the schools full-time educators.
It is an honor to have been chosen in the top five medical schools for Hispanics, said Pedro Mancias, M.D., assistant dean in the Office of Diversity and Inclusion and associate professor of pediatric neurology. It is a testament to the value that UTHealth places on the Hispanic population we serve. We look forward to engaging the Hispanic population through means including premedical programs, on-site visits to our school and mentoring programs.
UTHealths outreach to minority students includes a pre-medical conference for underrepresented students, a six-week summer program that offers medical school preparation for underrepresented and disadvantaged freshman and sophomore college students and participation in the annual Houston Hispanic Forums Career and Education Day for students in grades 6-12.
Other institutions in The University of Texas System in the Top 10 were The University of Texas Health Science Center at San Antonio (No. 1), The University of Texas Southwestern Medical Center at Dallas (No. 3), and The University of Texas Medical Branch at Galveston (No. 6).
Here is the original post:
UTHealth Medical School Ranked Fourth by Hispanic Business Magazine